PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Total Operating Expense: Rp1,032,427 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:DVLA PT Darya-Varia Laboratoria Tbk ISX:DVLA
74 GF Score
Price Rp1,560.00
GF Value Rp1,845.86
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is PT Darya-Varia Laboratoria Tbk Total Operating Expense?

PT Darya-Varia Laboratoria Tbk ISX:DVLA 74 Total Operating Expense is Rp1,032,427 Mil as of Mar. 2026. GuruFocus rates ISX:DVLA with a GF Score™ of 74/100 and a GF Value™ of Rp1,845.86 (Modestly Undervalued). The stock has 4 warning signs investors should review.

PT Darya-Varia Laboratoria Tbk's Total Operating Expense for the three months ended in Mar. 2026 was Rp232,496 Mil. PT Darya-Varia Laboratoria Tbk's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was Rp1,032,427 Mil.

PT Darya-Varia Laboratoria Tbk Total Operating Expense Related Terms

PT Darya-Varia Laboratoria Tbk Total Operating Expense Historical Data

* Premium members only.

The historical data trend for PT Darya-Varia Laboratoria Tbk's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Darya-Varia Laboratoria Tbk Total Operating Expense Chart

PT Darya-Varia Laboratoria Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 806,899.70 831,151.44 797,930.49 900,499.15 1,006,873.87

PT Darya-Varia Laboratoria Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 206,942.93 227,832.87 241,090.71 331,007.37 232,495.57
ISX:DVLA
74GF Score
PT Darya-Varia Laboratoria Tbk ISX:DVLA
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Darya-Varia Laboratoria Tbk Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp1,032,427 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of Rp1,032,427 Mil mean?
PT Darya-Varia Laboratoria Tbk (ISX:DVLA) has a Total Operating Expense of Rp1,032,427 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on PT Darya-Varia Laboratoria Tbk and its competitors.
Is PT Darya-Varia Laboratoria Tbk's Total Operating Expense too high?
PT Darya-Varia Laboratoria Tbk's current Total Operating Expense is Rp1,032,427 Mil. Overall, PT Darya-Varia Laboratoria Tbk has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Darya-Varia Laboratoria Tbk's Total Operating Expense compare to ZTS and UTHR?
PT Darya-Varia Laboratoria Tbk's Total Operating Expense of Rp1,032,427 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on PT Darya-Varia Laboratoria Tbk and its competitors. PT Darya-Varia Laboratoria Tbk's current Total Operating Expense is Rp1,032,427 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Darya-Varia Laboratoria Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Darya-Varia Laboratoria Tbk (ISX:DVLA) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp1,845.86, compared to a current price of Rp1,560.00 — trading 15.5% below its estimated fair value. The current Total Operating Expense is Rp1,032,427 Mil. PT Darya-Varia Laboratoria Tbk's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For PT Darya-Varia Laboratoria Tbk (ISX:DVLA), the current Total Operating Expense is Rp1,032,427 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Darya-Varia Laboratoria Tbk stock appears to be undervalued. The current stock price of Rp1,560.00 is trading 15.5% below its estimated GF Value™ of Rp1,845.86. GuruFocus considers PT Darya-Varia Laboratoria Tbk to be Modestly Undervalued.

Key valuation signals for ISX:DVLA:

  • Total Operating Expense: Rp1,032,427 Mil
  • GF Value™: Rp1,845.86 vs. price of Rp1,560.00 (15.5% below fair value)
  • GF Score™: 74/100 with 4 warning signs

No single metric tells the full story. See the ISX:DVLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Darya-Varia Laboratoria Tbk Business Description

Address Jalan. R.A. Kartini Kav. 8, 18th-19th Floor, South Quarter, Tower C, Jakarta, IDN, 12430
PT Darya-Varia Laboratoria Tbk (Darya-Varia) is operating in the pharmaceutical industry. It is engaged in the manufacture and trade of pharmaceutical products, human, traditional medicines, pharmaceutical materials, raw materials for traditional medicines, inorganic base chemicals, organic base chemicals, equipment for surgery, medical and dental care, and equipment, orthopedic equipment, prosthetic, eyeglasses, laboratory and health equipment from glass, cosmetics, wholesaler of pharmaceutical, traditional medicine, chemical base materials, laboratory testing services, periodic inspection services, and many more activities. Its business segments include: prescription drugs; consumer health products, which derives key revenue; export and toll manufacturing services; and services.
74GF Score

Get the complete analysis for ISX:DVLA

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp1,560.00
Price
Rp1,845.86
GF Value